Prognostic impact of the combination of erythropoiesis-stimulating agents to cancer treatment: literature review

Overview of attention for article published in Supportive Care in Cancer, June 2013

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

policy: 1 policy source

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 16 Mendeley

Summary Policy documents Dimensions citations

So far, Altmetric has seen 1 policy document that references this research output.

Erythropoiesis‑stimulating agents (epoetin and darbepoetin) for treating anaemia in people with cancer having chemotherapy: Anaemia (cancer-treatment induced) - erythropoiesis-stimulating agents (epoetin and darbepoetin) (inc rev TA142): evaluation report

Cited by National Institute for Health and Care Excellence on 15 Apr 2014

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.